What drugs does GENMAB US, INC. make?

GENMAB US, INC. has 1 FDA-approved drugs.

What therapeutic areas does GENMAB US, INC. focus on?

GENMAB US, INC. focuses primarily on Oncology and Metabolic and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

GENMAB US, INC.

OncologyMetabolicGastroenterology

Biotech

GENMAB US, INC. is a biotechnology company focused on Oncology, Metabolic, Gastroenterology.

2023

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 98%

1 drugs Phase 3: 9 Phase 2: 7 Phase 1: 31

Metabolic 1%

0 drugs Phase 1: 1

Gastroenterology 1%

0 drugs Phase 1: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Takeda big-pharma

Oncology, Gastroenterology, Metabolic

Pfizer big-pharma

Oncology, Gastroenterology

ASTELLAS specialty

Oncology, Gastroenterology, Metabolic

Amgen biotech

Oncology, Metabolic, Gastroenterology

EMD SERONO INC biotech

Oncology, Metabolic, Gastroenterology

GENMAB US, INC.

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info